InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Kavanagh Sarah B, 董事. Director active across 2 companies, notably Bausch Health Companies Inc.. Aggregated, 12 reports have been recorded. Activity tracked since 30 April 2021. The latest transaction was disclosed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kavanagh Sarah B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
15,842 股@ US$15.780.0037% mcap67.5% 占其流量Common Shares, No Par ValueSEC:0001860742-26-000077:0
45,871 股0Common Shares, No Par ValueSEC:0000885590-26-000077:0
20,338 股0Common Shares, No Par ValueSEC:0001127602-25-015802:0
54,347 股0Common Shares, No Par ValueSEC:0001127602-25-015037:0
14,696 股0Common Shares, No Par ValueSEC:0001127602-24-021756:0
35,360 股0Common Shares, No Par ValueSEC:0001127602-24-016027:0
29,205 股0Common Shares, No Par ValueSEC:0001127602-23-016285:0
12,857 股0Common Shares, No Par ValueSEC:0001127602-23-014702:0
6,692 股@ US$17.1232.5% 占其流量Common Shares, No Par ValueSEC:0001127602-23-013570:0
34,387 股0Common Shares, No Par ValueSEC:0001127602-22-018211:0
12,500 股0Common Shares, No Par ValueSEC:0000899243-22-017858:0
7,645 股0Common Shares, No Par ValueSEC:0001127602-21-014908:0
12 条申报中的 12 条
About Kavanagh Sarah B
Sarah B. Kavanagh is a Director at Bausch Health Companies Inc. and Bausch & Lomb Corp. In this role, she participates in the governance of these companies and strategic decision-making. Sarah brings expertise in health and biotechnology, enabling her to contribute to overseeing operations and guiding these companies' strategic direction. Her commitment to innovation and efficiency is essential for their success.
